Recalibration of the HAS-BLED score: Should hemorrhagic stroke account for one or two points?

Chest

Volumn 149, Issue 2, 2016, Pages 311-314

  Nielsen, Peter Brønnum ^a   Larsen, Torben Bjerregaard ^a   Lip, Gregory Y H ^a,b  

^a AALBORG UNIVERSITY   (Denmark)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; Cardiology; Clinical decision making; Stroke

Indexed keywords

ACCURACY; ADULT; AGED; ATRIAL FIBRILLATION; BLEEDING; BRAIN HEMORRHAGE; CALIBRATION; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; FEMALE; HAS BLED SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; BLOOD; CEREBRAL HEMORRHAGE; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; INTERNATIONAL NORMALIZED RATIO; MULTICENTER STUDY; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84958068968     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1509     Document Type: Article

References (16)

1. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-867.
2. Camm AJ, Lip GY, De Caterina R, et al; and the ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10):1385-1413.
3. January CT, Wann FL, Joseph F, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol. 2014;64(21):2246-2280.
4. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429.
5. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-1100.
6. Marsh EB, Gottesman RF. Brain hemorrhage: restarting anticoagulation after intracranial hemorrhage. Nat Rev Neurol. 2011;7(3):130-132.
7. Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY. Restarting anticoagulant treatment after intracranial haemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality and bleeding: a nationwide cohort study. Circulation. 2015;132(6):517-525.
8. Lip GY, Nielsen PB, Skjøth F, Lane DA, Rasmussen LH, Larsen TB. The value of the European Society of Cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study. Chest. 2014;146(5):1337-1346.
9. Johnsen SP, Overvad K, Sørensen HT, Tjønneland A, Husted SE. Predictive value of stroke and transient ischemic attack discharge diagnoses in the Danish National Registry of Patients. J Clin Epidemiol. 2002;55(6):602-607.
10. Newson R. Comparing the predictive powers of survival models using Harrell's C or Somers' D. Stata J. 2010;10(3):339-358.
11. Wolbers M, Koller MT, Witteman JC, Steyerberg EW. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009;20(4):555-561.
12. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation. 2008;117(15):1918-1926.
13. Pencina MJ, D'Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11-21.
14. Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics. 2005;61(1):223-229.
15. Pencina MJ, D'Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med. 2010;48(12):1703-1711.
16. Aguilar MI, Hart RG, Kase CS, et al. Treatment of warfarinassociated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc. 2007;82(1):82-92.